Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Quanterix Corporation Common Stock (QTRX)

Laboratory Analytical Instruments

https://www.quanterix.com

Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum and other fluids which are undetectable using conventional, analog immunoassay technologies. The company has developed Simoa technology which is a method of detection of proteins and has the capability of analyzing nearly six biomarkers per test, with anticipated expansion capability.

900 MIDDLESEX TURNPIKE
BILLERICA, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/07/2017

Market Cap

478,969,920

Shares Outstanding

37,830,000

Weighted SO

37,829,746

Total Employees

N/A

Upcoming Earnings

08/05/2024

Similar Tickers

BBLG --.--%

HSCS --.--%

TIVC --.--%

VVOS --.--%

TLIS --.--%

KIDS --.--%

OFIX --.--%

SGHT --.--%

NPCE --.--%

Beta

1.3890

Last Div

0.0000

Range

10.5-29.7

Chg

1.1300

Avg Vol

463467

Mkt Cap

478969920

Exch

NASDAQ

Country

US

Phone

617 301 9400

DCF Diff

8.4867

DCF

22.7666

Div Yield

0.0000

P/S

3.7178

EV Multiple

-9.7770

P/FV

1.4208

Div Yield %

0.0000

P/E

-12.0482

PEG

-0.5320

Payout

0.0000

Current Ratio

9.7426

Quick Ratio

8.9870

Cash Ratio

1.2521

DSO

90.0494

DIO

176.1347

Op Cycle

266.1842

DPO

45.1655

CCC

221.0187

Gross Margin

0.5438

Op Margin

-0.4573

Pretax Margin

-0.3033

Net Margin

-0.3082

Eff Tax Rate

-0.0164

ROA

-0.0966

ROE

-0.1152

ROCE

-0.1576

NI/EBT

1.0164

EBT/EBIT

0.6631

EBIT/Rev

-0.4573

Debt Ratio

0.0962

D/E

0.1175

LT Debt/Cap

0.0943

Total Debt/Cap

0.1052

Int Coverage

-4.7554

CF/Debt

-0.8881

Equity Multi

1.2213

Rec Turnover

4.0533

Pay Turnover

8.0814

Inv Turnover

2.0723

FA Turnover

3.6184

Asset Turnover

0.3132

OCF/Share

-0.9168

FCF/Share

-1.0501

Cash/Share

7.7431

OCF/Sales

-0.2728

FCF/OCF

1.1454

CF Coverage

-0.8881

ST Coverage

-7.7692

CapEx Coverage

-6.8796

Div&CapEx Cov

-6.8796

P/BV

1.4208

P/B

1.4208

P/S

3.7178

P/E

-12.0482

P/FCF

-11.8978

P/OCF

-13.6127

P/CF

-13.6127

PEG

-0.5320

P/S

3.7178

EV Multiple

-9.7770

P/FV

1.4208

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Apr 02, 22:50 $TOCKHOLDER ALERT: The M&A Class Action Firm Urges Shareholders of FNA, BECN, QTRX, PLYA to Take Action GlobeNewswire Inc. Feb 14, 23:30 $TOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – EVGR, QTRX, RKDA, EBTC GlobeNewswire Inc. Feb 14, 22:48 Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Feb 12, 02:19 Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Feb 08, 19:05 Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Feb 01, 15:37 Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Jan 25, 18:45 Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Jan 12, 21:48 Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Jan 10, 00:43 Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Jan 05, 17:19 Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Jan 01, 17:17 Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Dec 29, 01:15 Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Dec 21, 19:03 Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Dec 08, 22:26 Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire Inc. Nov 24, 21:42 Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Revenue Product Segmentation